Post-marketing surveillance of long-term administration of donepezil hydrochloride -Investigation of the clinical condition and safety in patients with Alzheimer's Disease
Not Applicable
- Conditions
- Alzheimer's Disease
- Registration Number
- JPRN-jRCT1080221231
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
Patients diagnosed with Alzheimer's Disease by Diagnostic and Statistical Manual of Mental Disorders (DSM-IV).
-Patients diagnosed with mild or moderate Alzheimer's Disease, applicable to FAST score 4 or 5.
Exclusion Criteria
-Patients with history of hypersensitivity to component of Aricept or piperidine derivative.
-Patients registered for this survey before.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Test of cognitive function
- Secondary Outcome Measures
Name Time Method